BioPlus Acquisition Corp. (NASDAQ:BIOSU) Shares Sold by Walleye Capital LLC

Walleye Capital LLC cut its stake in shares of BioPlus Acquisition Corp. (NASDAQ:BIOSUGet Rating) by 21.7% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 50,115 shares of the company’s stock after selling 13,885 shares during the quarter. Walleye Capital LLC’s holdings in BioPlus Acquisition were worth $500,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Spartan Fund Management Inc. acquired a new position in shares of BioPlus Acquisition during the first quarter worth about $1,866,000. Robinson Capital Management LLC lifted its stake in BioPlus Acquisition by 55.2% during the first quarter. Robinson Capital Management LLC now owns 25,293 shares of the company’s stock worth $252,000 after purchasing an additional 9,000 shares during the last quarter. State Street Corp purchased a new stake in BioPlus Acquisition during the first quarter worth approximately $184,000. Wealthspring Capital LLC lifted its stake in BioPlus Acquisition by 2.2% during the first quarter. Wealthspring Capital LLC now owns 188,665 shares of the company’s stock worth $1,881,000 after purchasing an additional 3,995 shares during the last quarter. Finally, Beryl Capital Management LLC purchased a new stake in BioPlus Acquisition during the fourth quarter worth approximately $2,500,000.

BioPlus Acquisition Stock Performance

BIOSU stock opened at $9.99 on Friday. The business has a 50 day moving average price of $10.03 and a 200 day moving average price of $10.01. BioPlus Acquisition Corp. has a fifty-two week low of $9.92 and a fifty-two week high of $10.07.

BioPlus Acquisition Profile

(Get Rating)

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

Read More

Want to see what other hedge funds are holding BIOSU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioPlus Acquisition Corp. (NASDAQ:BIOSUGet Rating).

Institutional Ownership by Quarter for BioPlus Acquisition (NASDAQ:BIOSU)

Receive News & Ratings for BioPlus Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPlus Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.